This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

SLB says Norwegian review of ChampionX deal heading for approval

( May 1, 2025, 05:54 GMT | Official Statement) -- MLex Summary: SLB said it will gain Norwegian competition approval for its acquisition of ChampionX acquisition "based on previously proposed remedies." It said this meant "no remedy will be required regarding the production chemistry business in Norway." The company said it would continue working with other competition authoritis and expected to close the deal in "Q2 or early Q3" this year. The statement follows:...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login